Consun Pharmaceutical Group (HKSE:01681) Cash per Share : HK$4.86 (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Consun Pharmaceutical Group's Cash per Share for the quarter that ended in Dec. 2024 was HK$4.86.

Consun Pharmaceutical Group Cash per Share Historical Data

The historical data trend for Consun Pharmaceutical Group's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group Cash per Share Chart

Consun Pharmaceutical Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash per Share

Get a 7-Day Free Trial

2.81

3.61

4.21

4.95

4.86

Consun Pharmaceutical Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash per Share	Get a 7-Day Free Trial															4.21	4.27	4.95	4.67	4.86

Consun Pharmaceutical Group Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Consun Pharmaceutical Group's Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	4127.281	/	849
	=	4.86

Consun Pharmaceutical Group's Cash per Share for the quarter that ended in Dec. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	4127.281	/	849
	=	4.86

Consun Pharmaceutical Group (HKSE:01681) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Consun Pharmaceutical Group Cash per Share Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Consun Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » Cash per Share

Traded in Other Exchanges

CPHGF:USA C1P:Germany

Address

71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN

Website

https://www.chinaconsun.com

Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Executives

Fmr Llc	2201 Interest of corporation controlled by you
Central Success Developments Limited	2101 Beneficial owner
Aali Resources Limited	2201 Interest of corporation controlled by you
Bos Trustee Limited	2301 Trustee
Assicurazioni Generali Spa	2201 Interest of corporation controlled by you
Gl China Long Equity Opportunities Fund Lp	2201 Interest of corporation controlled by you
Li Zhenfu	2201 Interest of corporation controlled by you
An Meng	2101 Beneficial owner
Zhang Lihua	2202 Interest of your spouse
Double Grace International Limited	2101 Beneficial owner
Li Qian	2101 Beneficial owner
An Yubao	2101 Beneficial owner
Bos Trustee Limited As Trustee	2201 Interest of corporation controlled by you

Consun Pharmaceutical Group Headlines

No Headlines